Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Efficient and selective biosynthesis of a precursor-directed FK506 analogue : paving the way for click chemistry
Authors:ID Goranovič, Dušan (Author)
ID Jenko, Branko (Author)
ID Ramšak, Barbara (Author)
ID Podgoršek Berke, Ajda (Author)
ID Bedrač, Leon (Author)
ID Horvat, Jaka (Author)
ID Šala, Martin (Author)
ID Makuc, Damjan (Author)
ID Carriche, Guilhermina M. (Author)
ID Silva, Luana (Author)
ID Lopez Krol, Aleksandra (Author)
ID Pšeničnik, Alen (Author)
ID Duran Alonso, Maria Beatriz (Author)
ID Avbelj, Martina (Author)
ID Stavber, Stojan, Institut "Jožef Stefan" (Author)
ID Plavec, Janez (Author)
ID Sparwasser, Tim (Author)
ID Müller, Rolf (Author)
ID Kosec, Gregor (Author)
ID Fujs, Štefan (Author)
ID Petković, Hrvoje (Author)
Files:.pdf PDF - Presentation file, download (3,26 MB)
MD5: 38677463FC15C2DE8D1F6500AF981EE8
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo IJS - Jožef Stefan Institute
Logo KI - National Institute of Chemistry
Abstract:The medically important immunosuppressant FK506 is a structurally complex macrolactone biosynthesized by a combined polyketide synthase and a nonribosomal peptide synthetase enzyme complex. Its acyltransferase domain 4 (AT4) selects an unusual extender unit, resulting in an allyl moiety on carbon 21 of the macrolactone backbone. Based on the AT4 domain, chemobiosynthetic processes have been developed that enable the introduction of diverse moieties at the carbon 21 position. However, the novel moieties that were introduced into the polyketide backbone are chemically inert. Reported here is a novel and efficient chemobiosynthetic approach that ensures high titer of an FK506 analogue containing a propargyl moiety. The novel FK506 analogue displays lower immunosuppression activity than FK506 with significantly reduced cytotoxicity. More importantly, the propargyl moiety contains a terminal alkyl group, which makes click chemistry reactions possible; this approach may potentially be translated to other medically important drugs of polyketide origin.
Publication status:Published
Publication version:Version of Record
Submitted for review:05.04.2024
Article acceptance date:05.02.2025
Publication date:10.03.2025
Publisher:ACS Publications
Year of publishing:2025
Number of pages:str. 619-630
Numbering:Vol. 88, issue 3
Source:ZDA
PID:20.500.12556/DiRROS-21968 New window
UDC:604.4:615.332
ISSN on article:0163-3864
DOI:10.1021/acs.jnatprod.4c00394 New window
COBISS.SI-ID:228597507 New window
Copyright:© 2025 The Authors.
Note:Soavtorji: Branko Jenko, Barbara Ramšak, Ajda Podgoršek Berke, Leon Bedrač, Jaka Horvat, Martin Šala, Damjan Makuc, Guilhermina M. Carriche, Luana Silva, Aleksandra Lopez Krol, Alen Pšeničnik, María Beatriz Durán Alonso, Martina Avbelj, Stojan Stavber, Janez Plavec, Tim Sparwasser, Rolf Müller, Gregor Kosec, Štefan Fujs, Hrvoje Petković;
Publication date in DiRROS:15.04.2025
Views:627
Downloads:191
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Journal of natural products
Shortened title:J. nat. prod.
Publisher:American Chemical Society, American Society of Pharmacognosy
ISSN:0163-3864
COBISS.SI-ID:1069327 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0116
Name:Mikrobiologija in biotehnologija živil in okolja

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:L4-5530
Name:Nova tehnologija za pridobivanje novih poliketidnih vodnic s kemijsko reaktivnimi skupinami

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0034
Name:Analitika in kemijska karakterizacija materialov ter procesov

Funder:German Research Foundation
Project number:318346496
Name:Targeting convergent mechanisms of inefficient immunity in tumors and chronic infections
Acronym:SFB 1292 TP18

Funder:German Research Foundation
Project number:490846870
Name:Heterogeneity and functional specialization of regulatory T cells in distinct microenvironments
Acronym:SFB355 TPA4

Funder:ARIS - Slovenian Research and Innovation Agency
Funding programme:Young Researcher Grant
Project number:53621

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:10.05.2025
Applies to:VoR

Secondary language

Language:Slovenian
Keywords:sekundarni metaboliti, biosinteza, FK506


Back